• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Gastroenterology

Molecular testing for Clostridium difficile may not predict disease activity

byAnees DaudandJames Jiang
September 9, 2015
in Gastroenterology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Based on this prospective cohort study, only half of the patients who tested positive for the Clostridium difficile (C. difficile) polymerase chain reaction (PCR) also tested positive for the toxin (Tox), and the patients who were tox negative and PCR positive (Tox-/PCR+) had diarrhea that was less severe, had fewer days of antibiotic exposure, and had less colonic inflammation compared to the Tox+/PCR+ group.  

2. Only about one in ten patients who were Tox-/PCR+ received a complete course of antibiotics. The number of days of diarrhea in Tox+/PCR+ was the most, whereas days of diarrhea was the same in the Tox-/PCR+ and Tox-/PCR- groups. Also, C. difficile infection (CDI) related complications/death was practically non-existent in the Tox-/PCR+ group, but was present in the Tox+/PCR+ group.

Evidence Rating Level: 2 (Good)

Study Rundown: C. difficile is a major health-care associated infection, and can lead to significant morbidity and cost. CDI has increased by more than 200% since the year 2000. While toxin assays were the mainstay for diagnoses, molecular assays which detect the presence of microbial DNA are now routinely used. However, there is concern that the molecular assay may be over-diagnosing CDI, since a significant number of patients may be colonized by the bacterium, but not have the toxin-mediated disease. This study was conducted to compare the outcomes amongst hospitalized patients with diarrhea depending on the positivity of these two tests.

The results showed that only half of the patients who tested positive for the C. difficile PCR also tested positive for the toxin, and the patients who were Tox-/PCR+ had diarrhea that was less severe, fewer days of antibiotic exposure, and less colonic inflammation compared to the Tox+/PCR+ group. Only about one in ten patients who were Tox-/PCR+ received a complete course of antibiotics. The number of days of diarrhea in Tox+/PCR+ was the most, whereas days of diarrhea was the same in the Tox-/PCR+ and Tox-/PCR- groups. Also, CDI-related complications/death was practically non-existent in the Tox-/PCR+ group, but was present in the Tox+/PCR+ group. The strength of the study was the generally wide inclusion criteria for hospital-associated diarrhea. The tests used for diagnosis are the most widely available ones, so the results are applicable. A weakness of the study was the fact that some Tox-/PCR+ patients were treated with antibiotics, which confounds the results.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

The Scan by 2 Minute Medicine®: Mammogram Recommendation Changes, COVID Called Off, Canadian Wildfires, and National Nurses Week

Impact of multispecies probiotic in preventing antibiotic-associated diarrhea unclear

Incidence of C. difficile infections decreasing in hospitalized children

Relevant Reading: Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection.

In-Depth [prospective cohort]: This was a single-center, prospective cohort study performed at the University of California Davis Medical Center from 2010 to 2012. Inclusion criteria were submission of a diarrheal stool sample seventy-two hours or longer after hospital admission. Formed stool samples were excluded. The toxin immunoassay and the PCR test were run on all samples, and separated into the following categories: Tox+/PCR+, Tox-/PCR+, Tox-/PCR-. The primary outcome was duration of diarrhea, and secondary outcome was CDI-related complications/death. Ten or more days of metronidazole or oral vancomycin was considered full treatment.

There were 1416 patients included, with the following breakdown: 131 Tox+/PCR+ (9.3%), 162 Tox-/PCR+ (11.4%), 1123 Tox-/PCR- (79.3%). Of the patients with the positive PCR, only 44.7% also had toxin detected. The average number of days of diarrhea was 2 for both the Tox-/PCR- and Tox-/PCR+ groups, but it was 3 for Tox+/PCR+ group. There were ten CDI-related complications and eleven CDI-related deaths in the Tox+/PCR+ group, whereas there were no CDI-related complications and one CDI-related death in the Tox-/PCR+ group.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: C. difficileoverdiagnosis
Previous Post

Reference payments for colonoscopy may reduce cost without complication increase

Next Post

Psychiatric disorders linked with increased risk of violent re-offense in released prisoners

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Mammogram Recommendation Changes, COVID Called Off, Canadian Wildfires, and National Nurses Week

May 18, 2023
Probiotics improve colic, reduce GI disorders in infants
Gastroenterology

Impact of multispecies probiotic in preventing antibiotic-associated diarrhea unclear

September 26, 2022
Quick Take: Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials
Chronic Disease

Incidence of C. difficile infections decreasing in hospitalized children

September 5, 2022
#VisualAbstract: Dermatopathologists have varying perceptions on whether the overdiagnosis of different melanocytic skin lesions is a public health issue
StudyGraphics

#VisualAbstract: Dermatopathologists have varying perceptions on whether the overdiagnosis of different melanocytic skin lesions is a public health issue

April 28, 2022
Next Post
Psychiatric disorders linked with increased risk of violent re-offense in released prisoners

Psychiatric disorders linked with increased risk of violent re-offense in released prisoners

Food environment associated with gestational diabetes

Prevalence of type II diabetes on the rise since 1980s

Enzyme replacement therapy shows promise for rare lysosomal storage disease: The ARISE study

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
  • 2 Minute Medicine Rewind June 30, 2025
  • Weighted vests and resistance training confer similar outcomes for bone density in the elderly
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.